Method for enhancing delivery and uniformity of concentration of cellular creatine
Patent 5925378 Issued on July 20, 1999. Estimated Expiration Date: 
March 31, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 31, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod for reduction of cardiac mortality rate using pyrazolidine-3,5-diones Sorbose for inhibiting fermentation acids in the mouth Patent #: 4390523 InventorAssigneeApplicationNo. 829198 filed on 03/31/1997US Classes:424/466, Effervescent424/464, Tablets, lozenges, or pills424/489Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)ExaminersPrimary: Page, Thurman K.Assistant: Benston, William E. Jr. Attorney, Agent or FirmInternational ClassA61K 009/46AbstractA method for enhancing a stable concentration of cellular creatine in a human includes dissolving an effervescent containing an acidic edible salt form of creatine in water. Once the mixture has completely dissolved the solution is immediately ingested, and an effective amount of creatine is absorbed. Preferably, the effervescent is in the form of a tablet which contains creatine in the form of an edible salt, a mixture of acids, and sodium. | |
